by
Thomas Dworetzky, Contributing Reporter | April 13, 2017
This may lead to more men being screened, which, given a more conservative approach to treatment, may not be a bad idea, Dr. John Davis, a urology researcher at the University of Texas MD Anderson Cancer Center in Houston, suggested to the news agency.
“It’s not like doing less screening only cut back on overdiagnosis and over-treatment of low risk cancer,” he advised, adding, “it also decreased diagnosis of intermediate and high-risk potentially lethal disease.”
Ad Statistics
Times Displayed: 109208
Times Visited: 6638 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
These latest recommendations are in line with
similar ones from other groups, such as the American Urological Association.
The latter organization “commended” the USPSTF “for its decision to upgrade its recommendation for prostate cancer screening to a "C" for men ages 55 to 69.”
It called the draft recommendations “thoughtful and reasonable,” and stated that they are “in direct alignment with the AUA's clinical practice guideline and guidelines from most other major physician groups – including the American Cancer Society, the American College of Physicians, the American Society of Clinical Oncology and the National Comprehensive Cancer Network,” according to a statement.
Back to HCB News
